Losing your unwanted weight is now as basic as swallowing a pill as, in accordance with a new study, gastric balloon which is swallowed just like a pill — rather then surgically implanted — remains to apply and enables in significant weight reduction. Gastric balloon — generally known as the bariatric technology — involves inserting a compact silicon balloon filled with saline solution right into a patient’s stomach through an endoscopic procedure to make a a sense fullness in order that the patient loses the impulse to overeat.

The traditional procedures required endoscopy for placement and removal. However, the latest Elipse is definitely the first procedure-less gastric balloon. It can be swallowed just like a pill and gets inflated by a connected catheter with 550ml of fluid over Ten mins, then the catheter detaches. After four months, a valve opens to deflate this device for excretion with the body. \’Elipse can be a less invasive and reversible option to weightloss, which doesn\’t require anatomic modification,\’ said Ioannis Raftopoulos from Holyoke Hospital in america alone. \’Elipse may enable patients to keep at the healthy weight through repeat technique device without requiring anaesthesia, incisions, or surgical risks,\’ Raftopoulos added.

The findings indicated that at 4 months, the mean weight loss was 10 kg. The participants had 9.5 per cent total body volume loss. Mean waist circumference was reduced by 8 cm and haemoglobin A1c (HbA1c), way of measuring blood glucose control, was decreased by -0.16 percent. Also, improvements were noticed in the degrees of bad cholesterol. \’These results demonstrate clinically significant losing weight with Elipse, the very first procedure-free gastric balloon,\’ Raftopoulos noted. Within the study, 34 patients that has a mean bmi (BMI) of 34.4 kg/m2 swallowed one Elipse device, that is brimming with 550mL of filling fluid by using a thin delivery catheter which was then removed. Weight was measured every a fortnight, and metabolic parameters were assessed at baseline additionally, the end within the study.

The findings were presented at European Obesity Summit (EOS) 2016 in Sweden, recently.

About The Author